Trends in the incidence of transient ischemic attacks, premorbid risk factors and the use of preventive treatments in the population of Dijon, France from 1985 to 2004.

Détails

Ressource 1Télécharger: 000097049.pdf (160.13 [Ko])
Etat: Public
Version: Final published version
Licence: Non spécifiée
ID Serval
serval:BIB_37CA32887379
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Trends in the incidence of transient ischemic attacks, premorbid risk factors and the use of preventive treatments in the population of Dijon, France from 1985 to 2004.
Périodique
Cerebrovascular diseases
Auteur⸱e⸱s
Bejot Y., Rouaud O., Benatru I., Durier J., Caillier M., Couvreur G., Fromont A., Falvo N., Osseby G.V., Cottin Y., Zeller M., Millerot E., Marie C., Moreau T., Giroud M.
ISSN
1015-9770 (Print)
ISSN-L
1015-9770
Statut éditorial
Publié
Date de publication
2007
Peer-reviewed
Oui
Volume
23
Numéro
2-3
Pages
126-131
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Résumé
We describe the epidemiological trends of transient ischemic attack (TIA) in a 20-year population-based pilot study.
Trends in the incidence, risk factors and pre-TIA use of preventive treatments for TIA were observed from 1985 to 2004 according to the classic definition in the population of the city of Dijon, France (150,000 inhabitants).
The raw and standardized incidence of TIA were stable over time. We observed a significant increase in the mean age at TIA onset in women only. The prevalence of hypercholesterolemia and diastolic blood pressure > or =90 mm Hg among patients with TIA increased significantly. This contrasts with falls in smoking and in history of previous myocardial infarction.
The stability of classic TIA incidence, despite the rise in the proportion of elderly people, and the increase in the mean age at onset in women may be considered as a medical progress.
Mots-clé
Age Distribution, Age Factors, Aged, Aged, 80 and over, Anticoagulants/therapeutic use, Antihypertensive Agents/therapeutic use, Atrial Fibrillation/complications, Atrial Fibrillation/drug therapy, Atrial Fibrillation/epidemiology, Epidemiology/trends, Female, France/epidemiology, Humans, Hypercholesterolemia/complications, Hypercholesterolemia/epidemiology, Hypertension/complications, Hypertension/drug therapy, Hypertension/epidemiology, Incidence, Ischemic Attack, Transient/epidemiology, Ischemic Attack, Transient/etiology, Ischemic Attack, Transient/prevention & control, Male, Middle Aged, Myocardial Infarction/complications, Myocardial Infarction/drug therapy, Myocardial Infarction/epidemiology, Pilot Projects, Platelet Aggregation Inhibitors/therapeutic use, Population Surveillance, Registries/statistics & numerical data, Risk Factors, Sex Distribution, Sex Factors, Smoking/adverse effects, Smoking/epidemiology, Time Factors
Pubmed
Web of science
Création de la notice
22/08/2024 13:49
Dernière modification de la notice
23/08/2024 10:34
Données d'usage